Nearly Half Of Statin-Treated Patients Not Currently Reaching LDL-C Target

Almost half (48%) of statin-treated patients are not meeting target levels of low-density lipoprotein cholesterol (LDL-C), according to the results of a new international study, conducted by Merck Sharp & Dohme Limited and presented today at the European Society of Cardiology (ESC) congress in Barcelona, Spain.